Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration
小胶质细胞 Hv1 质子通道作为环境诱发的神经炎症和神经变性的介质
基本信息
- 批准号:10584577
- 负责人:
- 金额:$ 59.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-04 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal Disease ModelsAnti-Inflammatory AgentsAutopsyBehavioralBrainCellsClinical TrialsCoupledDataElectrophysiology (science)EnvironmentEnzyme-Linked Immunosorbent AssayEpigenetic ProcessGoalsHerbicidesHistone AcetylationHumanImmuneIn VitroInfectionInflammasomeInflammatoryInflammatory ResponseKnock-outKnockout MiceLinkMeasuresMediatingMediatorMicrogliaNADPH OxidaseNerve DegenerationNeurodegenerative DisordersParaquatParkinson DiseasePathway interactionsPatientsPharmaceutical PreparationsProductionProtonsReactive Oxygen SpeciesRegulationResearchRiskRoleSamplingSignal PathwaySignal TransductionTechniquesTestingTherapeuticbrain cellchromatin immunoprecipitationconditional knockoutdopaminergic neurondriving forceexperimental studyfirst respondergenetic approachgenetic inhibitorin vivoinhibitorneuroinflammationneuroprotectionneurotoxicitynovelpatch clamppharmacologicprotein aggregationresponsetoxicanttranscription factorvoltage
项目摘要
Abstract
Neuroinflammation is a driving force contributing to neurodegenerative diseases, including Parkinson's disease
(PD). Microglia are the primary immune cell of the brain and are among the first responders to infection, toxic
insult and aggregated proteins and contribute significantly to neuroinflammation and neurodegeneration. The
microglial inflammatory response, including inflammasome activation, has been demonstrated to be significantly
associated with PD. Paraquat (PQ) is a commonly used herbicide that has been linked to increased risk for PD.
PQ-induced neurodegeneration is tightly coupled to the activation of microglia and appears to require priming of
the microglial response. Therefore, factors that modulate the microglial inflammatory response could lead to
neuroprotection and slow the progression of neurodegenerative diseases. However, to date, no anti-
inflammatory drugs have proven successful in human clinical trials necessitating research on new targets. Hv1
(HVCN1) is a voltage-gated proton channel highly expressed on microglia in the brain and in other immune cells
in the body. This proton channel regulates the activity of NADPH oxidase and production of reactive oxygen
species in immune cells and especially microglia. Our preliminary data demonstrate that PQ directly increases
Hv1 levels in microglia, possibly through an epigenetic mechanism involving histone acetylation. Further, our
data demonstrate effects of PQ on the NLRP3 inflammasome that appear to be regulated by Hv1, providing a
potential mechanism contributing to PQ-induced microglial priming. This proposal seeks to test the hypothesis
that Hv1 regulates priming of microglia following PQ exposure through the NLRP3 inflammasome, leading to
neuroinflammation and neurodegeneration. The Specific Aims of this project are to 1) Determine mechanisms
of Hv1 regulation following paraquat exposure 2) Define the role of Hv1 in regulation of the NLRP3 inflammasome
following paraquat exposure and 3) Determine the contribution of microglial Hv1 and the NLRP3 inflammasome
in regulating neurodegeneration following paraquat exposure. Completion of these Aims will define regulatory
mechanisms for Hv1 and determine the role of Hv1 in regulation of the NLRP3 inflammasome activation and
their role in PQ-induced neuroinflammation and neurotoxicity. Together, these Aims will provide crucial
information on the function of a novel regulator of neuroinflammation, Hv1, and determine whether targeting Hv1
may be a viable therapeutic strategy in toxicant-induced neurodegeneration.
摘要
神经炎症是导致包括帕金森病在内的神经退行性疾病的驱动力
(PD)。小胶质细胞是大脑的主要免疫细胞,并且是感染、毒性和免疫缺陷的第一反应者。
损伤和聚集蛋白质并显著促进神经炎症和神经变性。的
小胶质细胞炎症反应,包括炎性小体激活,已被证明是显著的,
与PD有关。百草枯(PQ)是一种常用的除草剂,与PD风险增加有关。
PQ诱导的神经退行性变与小胶质细胞的激活紧密相关,并且似乎需要启动
小胶质细胞的反应因此,调节小胶质细胞炎症反应的因素可能导致
神经保护和减缓神经退行性疾病的进展。然而,到目前为止,没有反-
炎性药物在人类临床试验中已被证明是成功的,需要对新靶点进行研究。HV1
(HVCN 1)是在脑中的小胶质细胞和其它免疫细胞中高度表达的电压门控质子通道
在体内该质子通道调节NADPH氧化酶的活性和活性氧的产生
免疫细胞,特别是小胶质细胞。我们的初步数据表明,PQ直接增加
小胶质细胞中的hv 1水平,可能通过涉及组蛋白乙酰化的表观遗传机制。此外,我们的
数据表明PQ对NLRP 3炎性小体的影响似乎受Hv 1调节,提供了一个
有助于PQ诱导的小胶质细胞启动的潜在机制。这一提议旨在检验这一假设
Hv 1通过NLRP 3炎性小体调节PQ暴露后小胶质细胞的启动,导致
神经炎症和神经变性。本项目的具体目标是:1)确定机制
2)确定Hv 1在调节NLRP 3炎性小体中的作用
3)确定小胶质细胞Hv 1和NLRP 3炎性小体的作用
在调节百草枯暴露后的神经退化方面的作用。这些目标的完成将定义监管
Hv 1的机制,并确定Hv 1在调节NLRP 3炎性小体活化中的作用,
它们在PQ诱导的神经炎症和神经毒性中的作用。这些目标将共同提供至关重要的
关于神经炎症新调节因子Hv 1功能的信息,并确定是否靶向Hv 1
可能是一个可行的治疗策略,在毒物诱导的神经变性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason R Richardson其他文献
Jason R Richardson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason R Richardson', 18)}}的其他基金
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration
小胶质细胞 Hv1 质子通道作为环境诱发的神经炎症和神经变性的介质
- 批准号:
10714415 - 财政年份:2022
- 资助金额:
$ 59.31万 - 项目类别:
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration
小胶质细胞 Hv1 质子通道作为环境诱发的神经炎症和神经变性的介质
- 批准号:
10391980 - 财政年份:2022
- 资助金额:
$ 59.31万 - 项目类别:
Health Disparities in Alzheimers and Related Diseases
阿尔茨海默病和相关疾病的健康差异
- 批准号:
10459366 - 财政年份:2020
- 资助金额:
$ 59.31万 - 项目类别:
Health Disparities in Alzheimers and Related Diseases
阿尔茨海默病和相关疾病的健康差异
- 批准号:
10238143 - 财政年份:2020
- 资助金额:
$ 59.31万 - 项目类别:
Health Disparities in Alzheimers and Related Diseases
阿尔茨海默病和相关疾病的健康差异
- 批准号:
10685967 - 财政年份:2020
- 资助金额:
$ 59.31万 - 项目类别:
Mechanism of Gene Environment Interactions in Alzheimer's Disease
阿尔茨海默病基因环境相互作用的机制
- 批准号:
9978067 - 财政年份:2018
- 资助金额:
$ 59.31万 - 项目类别:
Mechanism of Gene Environment Interactions in Alzheimer's Disease
阿尔茨海默病基因环境相互作用的机制
- 批准号:
9302779 - 财政年份:2016
- 资助金额:
$ 59.31万 - 项目类别:
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD
农药引起的神经行为缺陷的机制:与多动症的相关性
- 批准号:
7900822 - 财政年份:2009
- 资助金额:
$ 59.31万 - 项目类别:
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD
农药引起的神经行为缺陷的机制:与多动症的相关性
- 批准号:
8720193 - 财政年份:2007
- 资助金额:
$ 59.31万 - 项目类别:
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD
农药引起的神经行为缺陷的机制:与多动症的相关性
- 批准号:
7337586 - 财政年份:2007
- 资助金额:
$ 59.31万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 59.31万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 59.31万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 59.31万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 59.31万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 59.31万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 59.31万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 59.31万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 59.31万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 59.31万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 59.31万 - 项目类别: